300979984	300979984	CD	B-NP	O
|	|	NN	I-NP	O
LMH	LMH	NN	I-NP	O
|	|	NN	I-NP	O
36732251	36732251	CD	I-NP	O
|	|	NN	I-NP	O
|	|	NN	I-NP	O
0183933	0183933	CD	B-NP	O
|	|	CC	I-NP	O
4/6/2003	4/6/2003	CD	I-NP	O
12	12	CD	I-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
AM	AM	VBP	B-VP	O
|	|	JJ	B-NP	O
hypovolemia	hypovolemia	NN	I-NP	O
,	,	,	O	O
chronic	chronic	JJ	B-NP	O
renal	renal	JJ	I-NP	O
insufficiency	insufficiency	NN	I-NP	O
|	|	NN	I-NP	O
|	|	NN	I-NP	O
DIS	DIS	NNP	I-NP	O
|	|	NNP	I-NP	O
Admission	Admission	NNP	I-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
5/29/2003	5/29/2003	CD	B-NP	O
Report	Report	NNP	I-NP	O
Status	Status	NNP	I-NP	O
:	:	:	O	O
Discharge	Discharge	NNP	B-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
1/28/2003	1/28/2003	CD	B-NP	O
******	******	SYM	I-NP	O
DISCHARGE	DISCHARGE	NN	I-NP	O
ORDERS	ORDERS	NN	I-NP	O
******	******	SYM	B-VP	O
HEPPEARD	HEPPEARD	NN	B-NP	O
,	,	,	O	O
JASPER	JASPER	NN	B-NP	O
280-33-70-9	280-33-70-9	CD	I-NP	O
Rage	Rage	NNP	I-NP	O
La	La	NNP	I-NP	O
Service	Service	NNP	I-NP	O
:	:	:	O	O
MED	MED	NNP	B-NP	O
DISCHARGE	DISCHARGE	NNP	I-NP	O
PATIENT	PATIENT	NNP	I-NP	O
ON	ON	NNP	I-NP	O
:	:	:	O	O
7/1/03	7/1/03	CD	B-NP	O
AT	AT	NN	I-NP	O
04	04	CD	I-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
PM	PM	NNP	I-NP	O
CONTINGENT	CONTINGENT	NNP	I-NP	O
UPON	UPON	NNP	I-NP	O
Not	Not	NNP	I-NP	O
Applicable	Applicable	NNP	I-NP	O
WILL	WILL	NNP	I-NP	O
D/C	D/C	NNP	I-NP	O
ORDER	ORDER	NNP	I-NP	O
BE	BE	NNP	I-NP	O
USED	USED	NNP	I-NP	O
AS	AS	NNP	I-NP	O
THE	THE	NNP	I-NP	O
D/C	D/C	NNP	I-NP	O
SUMMARY	SUMMARY	NNP	I-NP	O
:	:	:	O	O
YES	YES	NNP	B-NP	O
Attending	Attending	NNP	I-NP	O
:	:	:	O	O
ALA	ALA	NN	B-NP	O
,	,	,	O	O
ANIBAL	ANIBAL	NNP	B-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
CODE	CODE	NNP	I-NP	O
STATUS	STATUS	NNP	I-NP	O
:	:	:	O	O
Full	Full	JJ	B-NP	O
code	code	NN	I-NP	O
DISPOSITION	DISPOSITION	NN	I-NP	O
:	:	:	O	O
Home	Home	NN	B-NP	O
DISCHARGE	DISCHARGE	NN	I-NP	O
MEDICATIONS	MEDICATIONS	NNS	I-NP	O
:	:	:	O	O
ECASA	ECASA	NNP	B-NP	O
-LRB-	-LRB-	NNP	I-NP	O
ASPIRIN	ASPIRIN	NNP	I-NP	O
ENTERIC	ENTERIC	NNP	I-NP	O
COATED	COATED	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
81	81	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
QD	QD	NNP	I-NP	O
PHOSLO	PHOSLO	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
CALCIUM	CALCIUM	NNP	I-NP	O
ACETATE	ACETATE	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
1	1	CD	I-NP	O
,	,	,	I-NP	O
334	334	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
AC	AC	NNP	I-NP	O
LASIX	LASIX	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
FUROSEMIDE	FUROSEMIDE	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
40	40	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
BID	BID	NNP	I-NP	O
GLIPIZIDE	GLIPIZIDE	NNP	I-NP	O
10	10	CD	I-NP	O
MG	MG	NN	I-NP	O
PO	PO	NN	I-NP	O
QD	QD	NN	I-NP	O
LOPRESSOR	LOPRESSOR	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
METOPROLOL	METOPROLOL	NN	I-NP	O
TARTRATE	TARTRATE	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
50	50	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
BID	BID	NNP	I-NP	O
Food/Drug	Food/Drug	NNP	I-NP	O
Interaction	Interaction	NNP	I-NP	O
Instruction	Instruction	NNP	I-NP	O
Take	Take	NNP	I-NP	O
consistently	consistently	RB	B-ADVP	O
with	with	IN	B-PP	O
meals	meal	NNS	B-NP	O
or	or	CC	B-PP	O
on	on	IN	B-PP	O
empty	empty	JJ	B-NP	O
stomach	stomach	NN	I-NP	O
.	.	.	O	O

NITROGLYCERIN	NITROGLYCERIN	NN	B-NP	B-protein
1/150	1/150	CD	I-NP	I-protein
-LRB-	-LRB-	HYPH	I-NP	O
0.4	0.4	CD	I-NP	O
MG	MG	NN	I-NP	O
-RRB-	-RRB-	HYPH	B-NP	O
1	1	CD	I-NP	O
TAB	TAB	NN	I-NP	O
SL	SL	NN	I-NP	O
q5min	q5min	NN	I-NP	O
x	x	SYM	B-NP	O
3	3	CD	I-NP	O
PRN	PRN	NN	I-NP	O
chest	chest	NN	I-NP	O
pain	pain	NN	I-NP	O
Alert	Alert	NNP	I-NP	O
overridden	overridden	JJ	I-NP	O
:	:	:	O	O
Override	Override	NN	B-NP	O
added	add	VBN	B-VP	O
on	on	IN	B-PP	O
10/24/03	10/24/03	CD	B-NP	O
by	by	IN	B-PP	O
MESTAYER	MESTAYER	NNP	B-NP	O
,	,	,	O	O
GALEN	GALEN	NNP	B-NP	O
M.	M.	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
DEFINITE	DEFINITE	NNP	I-NP	O
ALLERGY	ALLERGY	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
OR	OR	NNP	I-NP	O
SENSITIVITY	SENSITIVITY	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
to	to	TO	B-PP	O
NITRATES	NITRATES	NNP	B-NP	O
Reason	Reason	NNP	I-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
tolerates	tolerate	VBZ	B-VP	O
NORVASC	NORVASC	NNP	B-NP	O
-LRB-	-LRB-	NNP	I-NP	O
AMLODIPINE	AMLODIPINE	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
10	10	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
QD	QD	NNP	I-NP	O
Food/Drug	Food/Drug	NNP	I-NP	O
Interaction	Interaction	NNP	I-NP	O
Instruction	Instruction	NNP	I-NP	O
Avoid	Avoid	NNP	I-NP	O
grapefruit	grapefruit	NN	I-NP	O
unless	unless	IN	B-SBAR	O
MD	MD	NN	B-NP	B-DNA
instructs	instruct	NNS	I-NP	I-DNA
otherwise	otherwise	RB	B-ADVP	O
.	.	.	O	O

NEPHROCAPS	NEPHROCAPS	NN	B-NP	O
-LRB-	-LRB-	NN	I-NP	O
NEPHRO-VIT	NEPHRO-VIT	NN	I-NP	O
RX	RX	NN	I-NP	O
-RRB-	-RRB-	HYPH	B-NP	O
1	1	CD	I-NP	O
TAB	TAB	NN	I-NP	B-protein
PO	PO	NNP	I-NP	O
QD	QD	NNP	I-NP	O
Override	Override	NNP	I-NP	O
Notice	Notice	NNP	I-NP	O
:	:	:	O	O
Override	Override	NNP	B-NP	O
added	add	VBD	B-VP	O
on	on	IN	B-PP	O
1/15/03	1/15/03	CD	B-NP	O
by	by	IN	B-PP	O
SANTACROCE	SANTACROCE	NNP	B-NP	O
,	,	,	O	O
JULIO	JULIO	NNP	B-NP	O
A.	A.	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
on	on	IN	B-PP	O
order	order	NN	B-NP	O
for	for	IN	B-PP	O
ZOCOR	ZOCOR	NN	B-NP	B-protein
PO	PO	NN	I-NP	O
OTHER	OTHER	NN	I-NP	O
QHS	QHS	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
ref	ref	NN	I-NP	O
#	#	#	B-NP	O
29629025	29629025	CD	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
POTENTIALLY	POTENTIALLY	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
NIACIN	NIACIN	NN	B-NP	B-protein
,	,	,	O	O
VIT	VIT	NN	B-NP	B-protein
.	.	.	O	O

B-3	B-3	NN	B-NP	B-protein
&	&	CC	I-NP	O
SIMVASTATIN	SIMVASTATIN	NN	I-NP	O
Reason	Reason	NN	I-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
aware	aware	JJ	B-NP	O
Previous	Previous	JJ	I-NP	O
override	override	NN	I-NP	O
information	information	NN	I-NP	O
:	:	:	O	O
Override	Override	NN	B-NP	O
added	add	VBN	B-VP	O
on	on	IN	B-PP	O
1/15/03	1/15/03	CD	B-NP	O
by	by	IN	B-PP	O
SELBE	SELBE	NNP	B-NP	O
,	,	,	O	O
CHASE	CHASE	NNP	B-NP	O
A.	A.	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
POTENTIALLY	POTENTIALLY	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
SIMVASTATIN	SIMVASTATIN	NNP	B-NP	O
&	&	CC	I-NP	O
NIACIN	NIACIN	NNP	I-NP	O
,	,	,	O	O
VIT	VIT	NNP	B-NP	O
.	.	.	O	O

B-3	B-3	NN	B-NP	B-protein
Reason	Reason	NNP	I-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
aware	aware	JJ	B-NP	O
LIPITOR	LIPITOR	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
ATORVASTATIN	ATORVASTATIN	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
80	80	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
QD	QD	NNP	I-NP	O
Alert	Alert	NNP	I-NP	O
overridden	overridden	JJ	I-NP	O
:	:	:	O	O
Override	Override	NN	B-NP	O
added	add	VBN	B-VP	O
on	on	IN	B-PP	O
7/1/03	7/1/03	CD	B-NP	O
by	by	IN	B-PP	O
:	:	:	O	O
POTENTIALLY	POTENTIALLY	NN	B-NP	O
SERIOUS	SERIOUS	NN	I-NP	O
INTERACTION	INTERACTION	NN	I-NP	O
:	:	:	O	O
NIACIN	NIACIN	NN	B-NP	B-protein
,	,	,	O	O
VIT	VIT	NN	B-NP	B-protein
.	.	.	O	O

B-3	B-3	NN	B-NP	B-protein
&	&	CC	I-NP	O
ATORVASTATIN	ATORVASTATIN	NN	I-NP	O
CALCIUM	CALCIUM	NN	I-NP	O
Reason	Reason	NN	I-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
Patient	Patient	NN	B-NP	O
requires	require	VBZ	B-VP	O
.	.	.	O	O

PREVACID	PREVACID	NN	B-NP	O
-LRB-	-LRB-	NN	I-NP	O
LANSOPRAZOLE	LANSOPRAZOLE	NN	I-NP	O
-RRB-	-RRB-	NNP	B-NP	O
15	15	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
QD	QD	NNP	I-NP	O
POTASSIUM	POTASSIUM	NNP	I-NP	O
CHLORIDE	CHLORIDE	NNP	I-NP	O
SUSTAINED	SUSTAINED	NNP	I-NP	O
RELEASE	RELEASE	NNP	I-NP	O
40	40	CD	I-NP	O
MEQ	MEQ	NN	I-NP	O
PO	PO	NN	I-NP	O
QD	QD	NN	I-NP	O
Ingredients	Ingredient	NNS	I-NP	O
contain	contain	VBP	B-VP	O
40	40	CD	B-NP	O
MEQ	MEQ	NN	I-NP	O
KCL	KCL	NN	I-NP	O
QD	QD	NN	I-NP	O
DIET	DIET	NN	I-NP	O
:	:	:	O	O
House	House	NNP	B-NP	O
/	/	SYM	B-NP	O
Low	Low	JJ	I-NP	O
chol/low	chol/low	NN	I-NP	O
sat	sat	NN	I-NP	O
.	.	.	O	O

fat	fat	JJ	B-NP	O
DIET	DIET	NN	I-NP	O
:	:	:	O	O
House	House	NN	B-NP	O
/	/	SYM	O	O
ADA	ADA	NN	B-NP	O
2100	2100	CD	I-NP	O
cals/dy	cals/dy	NN	I-NP	O
ACTIVITY	ACTIVITY	NN	I-NP	O
:	:	:	O	O
Resume	Resume	VB	B-VP	O
regular	regular	JJ	B-NP	O
exercise	exercise	NN	I-NP	O
FOLLOW	FOLLOW	NNP	I-NP	O
UP	UP	NNP	I-NP	O
APPOINTMENT	APPOINTMENT	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
S	S	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
:	:	:	O	O
Follow-up	Follow-up	NNP	B-NP	O
with	with	IN	B-PP	O
Dr.	Dr.	NNP	B-NP	O
Sorley	Sorley	NNP	I-NP	O
,	,	,	O	O
your	your	PRP$	B-NP	O
primary	primary	JJ	I-NP	O
care	care	NN	I-NP	O
provider	provider	NN	I-NP	O
at	at	IN	B-PP	O
UMIMHOC	UMIMHOC	NNP	B-NP	O
Ton	Ton	NNP	I-NP	O
Wi	Wi	NNP	I-NP	O
11/14/03	11/14/03	CD	I-NP	O
scheduled	schedule	VBN	B-VP	O
,	,	,	O	O
Please	Please	NN	B-NP	O
follow-up	follow-up	NN	I-NP	O
with	with	IN	B-PP	O
your	your	PRP$	B-NP	O
kidney	kidney	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
renal	renal	JJ	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
doctor	doctor	NN	I-NP	O
to	to	TO	B-VP	O
follow-up	follow-up	VB	I-VP	O
your	your	PRP$	B-NP	O
chronic	chronic	JJ	I-NP	O
renal	renal	JJ	I-NP	O
insufficiency	insufficiency	NN	I-NP	O
within	within	IN	B-PP	O
the	the	DT	B-NP	O
next	next	JJ	I-NP	O
2	2	CD	I-NP	O
weeks	week	NNS	I-NP	O
.	.	.	O	O

,	,	,	O	O
Please	Please	NN	B-NP	O
follow-up	follow-up	NN	I-NP	O
with	with	IN	B-PP	O
your	your	PRP$	B-NP	O
primary	primary	JJ	I-NP	O
care	care	NN	I-NP	O
provider	provider	NN	I-NP	O
to	to	TO	B-VP	O
re-schedule	re-schedule	VB	I-VP	O
your	your	PRP$	B-NP	O
colonoscopy	colonoscopy	NN	I-NP	O
.	.	.	O	O

,	,	,	O	O
ALLERGY	ALLERGY	NN	B-NP	O
:	:	:	O	O
Nitroglycerine	Nitroglycerine	NN	B-NP	O
-LRB-	-LRB-	NN	I-NP	O
nitroglycerin	nitroglycerin	NN	I-NP	O
i.v.	i.v.	JJ	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
ADMIT	ADMIT	NN	I-NP	O
DIAGNOSIS	DIAGNOSIS	NN	I-NP	O
:	:	:	O	O
r/o	r/o	NN	B-NP	O
mi	mi	NNS	I-NP	O
PRINCIPAL	PRINCIPAL	NNP	B-NP	O
DISCHARGE	DISCHARGE	NNP	I-NP	O
DIAGNOSIS	DIAGNOSIS	NNP	I-NP	O
;	;	:	O	O
Responsible	Responsible	JJ	B-ADJP	O
After	After	IN	B-PP	O
Study	Study	NN	B-NP	O
for	for	IN	B-PP	O
Causing	Cause	VBG	B-VP	O
Admission	Admission	NN	B-NP	O
-RRB-	-RRB-	NN	I-NP	O
hypovolemia	hypovolemia	NN	I-NP	O
,	,	,	O	O
chronic	chronic	JJ	B-NP	O
renal	renal	JJ	I-NP	O
insufficiency	insufficiency	NN	I-NP	O
OTHER	OTHER	NN	I-NP	O
DIAGNOSIS	DIAGNOSIS	NN	I-NP	O
;	;	:	O	O
Conditions	Condition	NNS	B-NP	O
,	,	,	O	O
Infections	Infection	NNS	B-NP	O
,	,	,	O	O
Complications	Complication	NNS	B-NP	O
,	,	,	O	O
affecting	affect	VBG	B-VP	O
Treatment/Stay	Treatment/Stay	NNP	B-NP	O
S/P	S/P	NNP	I-NP	O
CABG	CABG	NNP	I-NP	O
,	,	,	O	O
H/O	H/O	NNP	B-NP	O
POLYPECTOMY	POLYPECTOMY	NNP	I-NP	O
,	,	,	O	O
H/O	H/O	NNP	B-NP	O
NEPHROLITHIASIS	NEPHROLITHIASIS	NNP	I-NP	O
,	,	,	O	O
h/o	h/o	NN	B-NP	B-protein
chronic	chronic	JJ	I-NP	I-protein
renal	renal	JJ	I-NP	I-protein
insufficiency	insufficiency	NN	I-NP	I-protein
-LRB-	-LRB-	NN	I-NP	I-protein
H/O	H/O	NN	I-NP	I-protein
chronic	chronic	JJ	I-NP	I-protein
renal	renal	JJ	I-NP	I-protein
dysfunction	dysfunction	NN	I-NP	I-protein
-RRB-	-RRB-	NN	I-NP	I-protein
,	,	,	O	O
gout	gout	NN	B-NP	B-protein
-LRB-	-LRB-	NN	I-NP	I-protein
gout	gout	NN	I-NP	I-protein
-RRB-	-RRB-	NN	I-NP	I-protein
,	,	,	O	O
h/o	h/o	NN	B-NP	B-protein
gastritis/duodenitis	gastritis/duodenitis	NN	I-NP	I-protein
-LRB-	-LRB-	NN	I-NP	I-protein
H/O	H/O	NN	I-NP	I-protein
gastritis	gastritis	NN	I-NP	I-protein
-RRB-	-RRB-	NN	I-NP	I-protein
,	,	,	O	O
h/o	h/o	NN	B-NP	B-protein
hiatal	hiatal	JJ	I-NP	I-protein
hernia	hernia	NN	I-NP	I-protein
-LRB-	-LRB-	NN	I-NP	I-protein
H/O	H/O	NN	I-NP	I-protein
hiatal	hiatal	JJ	I-NP	I-protein
hernia	hernia	NN	I-NP	I-protein
-RRB-	-RRB-	NN	I-NP	I-protein
,	,	,	O	O
h/o	h/o	NN	B-NP	B-protein
GERD	GERD	NNP	I-NP	I-protein
-LRB-	-LRB-	NNP	I-NP	I-protein
H/O	H/O	NNP	I-NP	I-protein
esophageal	esophageal	JJ	I-NP	I-protein
reflux	reflux	NN	I-NP	I-protein
-RRB-	-RRB-	NN	I-NP	I-protein
,	,	,	O	O
h/o	h/o	NN	B-NP	B-protein
hypercholesterolemia	hypercholesterolemia	NN	I-NP	I-protein
-LRB-	-LRB-	NN	I-NP	I-protein
H/O	H/O	NN	I-NP	I-protein
elevated	elevate	VBD	B-VP	I-protein
cholesterol	cholesterol	NN	B-NP	I-protein
-RRB-	-RRB-	NN	I-NP	I-protein
,	,	,	O	O
htn	htn	NN	B-NP	B-protein
-LRB-	-LRB-	NN	I-NP	I-protein
hypertension	hypertension	NN	I-NP	I-protein
-RRB-	-RRB-	NN	I-NP	I-protein
,	,	,	O	O
CAD	CAD	NN	B-NP	O
s/p	s/p	NN	I-NP	O
cabg	cabg	NN	I-NP	O
OPERATIONS	OPERATIONS	NNS	I-NP	O
AND	AND	CC	I-NP	O
PROCEDURES	PROCEDURES	NNS	I-NP	O
:	:	:	O	O
An	An	DT	B-NP	O
ETT-MIBI	ETT-MIBI	NN	I-NP	B-DNA
was	be	VBD	B-VP	O
repeated	repeat	VBN	I-VP	O
on	on	IN	B-PP	O
6/13/03	6/13/03	CD	B-NP	O
and	and	CC	O	O
compared	compare	VBN	B-PP	O
with	with	IN	B-PP	O
the	the	DT	B-NP	O
one	one	CD	I-NP	O
of	of	IN	B-PP	O
4/12	4/12	CD	B-NP	O
showed	show	VBD	B-VP	O
interval	interval	JJ	B-NP	O
improvement	improvement	NN	I-NP	O
in	in	IN	B-PP	O
cardiac	cardiac	JJ	B-NP	O
status	status	NN	I-NP	O
.	.	.	O	O

Bruce	Bruce	NNP	B-NP	O
protocol	protocol	NN	I-NP	O
,	,	,	O	O
exercised	exercise	VBN	B-VP	O
for	for	IN	B-PP	O
5	5	CD	B-NP	O
:	:	SYM	I-NP	O
15	15	CD	I-NP	O
,	,	,	O	O
terminated	terminate	VBN	B-VP	O
due	due	JJ	B-ADJP	O
to	to	TO	B-VP	O
fatigue	fatigue	VB	I-VP	O
,	,	,	O	O
Max	Max	NN	B-NP	B-protein
HR	HR	NN	I-NP	O
:	:	:	O	O
112	112	CD	B-NP	O
-LRB-	-LRB-	HYPH	I-NP	O
77	77	CD	I-NP	O
%	%	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
,	,	,	O	O
BP	BP	NN	B-NP	B-protein
-LRB-	-LRB-	HYPH	O	O
148/75	148/75	CD	B-NP	O
-RRB-	-RRB-	NN	I-NP	O
,	,	,	O	O
no	no	DT	B-NP	O
stress	stress	NN	I-NP	O
arrythmias	arrythmia	NNS	I-NP	O
,	,	,	O	O
no	no	DT	B-NP	O
ischemic	ischemic	JJ	I-NP	O
EKG	EKG	NN	I-NP	O
changes	change	NNS	I-NP	O
,	,	,	O	O
no	no	DT	B-NP	O
perfusion	perfusion	NN	I-NP	O
defects	defect	NNS	I-NP	O
,	,	,	O	O
LV	LV	NN	B-NP	B-protein
EF	EF	NN	I-NP	I-protein
=	=	SYM	B-VP	O
61	61	CD	B-NP	O
%	%	NN	I-NP	O
.	.	.	O	O

OTHER	OTHER	NNP	B-NP	O
TREATMENTS/PROCEDURES	TREATMENTS/PROCEDURES	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
NOT	NOT	NNP	I-NP	O
IN	IN	NNP	I-NP	O
O.R.	O.R.	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
None	None	NNP	I-NP	O
.	.	.	O	O

BRIEF	BRIEF	NN	B-NP	O
RESUME	RESUME	NN	I-NP	O
OF	OF	IN	B-PP	O
HOSPITAL	HOSPITAL	JJ	B-NP	O
COURSE	COURSE	NN	I-NP	O
:	:	:	O	O
74M	74M	NN	B-NP	O
s/p	s/p	NN	I-NP	O
CABG	CABG	NN	I-NP	O
92	92	CD	I-NP	O
,	,	,	O	O
DM	DM	NN	B-NP	O
,	,	,	O	O
HTN	HTN	NN	B-NP	B-protein
,	,	,	O	O
CRI	CRI	NN	B-NP	B-protein
,	,	,	O	O
p/w	p/w	NN	B-NP	O
h/o	h/o	NN	I-NP	O
near-syncope	near-syncope	NN	I-NP	O
,	,	,	O	O
dizziness	dizziness	NN	B-NP	O
,	,	,	O	O
CP	CP	NN	B-NP	B-DNA
this	this	DT	B-NP	O
PM	PM	NN	I-NP	O
while	while	IN	B-SBAR	O
awaiting	await	VBG	B-VP	O
f/u	f/u	NN	B-NP	O
colonoscopy	colonoscopy	NN	I-NP	O
for	for	IN	B-PP	O
recent	recent	JJ	B-NP	O
polypectomy	polypectomy	NN	I-NP	O
.	.	.	O	O

+	+	SYM	O	O
diaphoresis	diaphoresis	NN	B-NP	O
,	,	,	O	O
no	no	DT	B-NP	O
SOB	SOB	NN	I-NP	B-protein
.	.	.	O	O

CP	CP	NN	B-NP	B-DNA
substernal	substernal	JJ	I-NP	O
no	no	DT	B-NP	O
radiation	radiation	NN	I-NP	O
.	.	.	O	O

+	+	SYM	B-NP	O
palps	palp	NNS	I-NP	O
.	.	.	O	O

Noted	Note	VBN	B-VP	O
to	to	TO	I-VP	O
be	be	VB	I-VP	O
hypotensive	hypotensive	JJ	B-NP	O
sent	sent	NN	I-NP	O
to	to	TO	B-PP	O
ED	ED	NN	B-NP	O
.	.	.	O	O

Pt	Pt	NN	B-NP	O
.	.	.	O	O

NPO	NPO	NN	B-NP	B-protein
except	except	IN	B-PP	O
meds	med	NNS	B-NP	O
for	for	IN	B-PP	O
colonscopy	colonscopy	NN	B-NP	O
x24hrs	x24hr	NNS	I-NP	O
,	,	,	O	O
took	take	VBD	B-VP	O
all	all	DT	B-NP	O
meds	med	NNS	I-NP	O
this	this	DT	B-NP	O
AM	AM	NN	I-NP	O
.	.	.	O	O

Pt	Pt	NN	B-NP	O
.	.	.	O	O

reports	report	NNS	B-NP	O
h/o	h/o	VBP	B-VP	O
3	3	CD	B-NP	O
episodes	episode	NNS	I-NP	O
of	of	IN	B-PP	O
CP	CP	NN	B-NP	B-DNA
1d	1d	CD	I-NP	O
PTA	PTA	NN	I-NP	O
relieved	relieve	VBN	B-VP	O
with	with	IN	B-PP	O
sl	sl	NN	B-NP	O
NTG	NTG	NN	I-NP	O
each	each	DT	B-NP	O
time	time	NN	I-NP	O
.	.	.	O	O

Pt	Pt	NN	B-NP	O
.	.	.	O	O

w	w	NN	B-NP	O
/	/	SYM	O	O
ETT-MIBI	ETT-MIBI	NN	B-NP	B-protein
4/12	4/12	CD	I-NP	I-protein
stopped	stop	VBD	B-VP	O
after	after	IN	B-PP	O
3min	3min	NN	B-NP	O
for	for	IN	B-PP	O
2	2	CD	B-NP	O
:	:	SYM	I-NP	O
1	1	CD	I-NP	O
AV	AV	NN	I-NP	O
block	block	NN	I-NP	O
and	and	CC	O	O
small	small	JJ	B-NP	O
area	area	NN	I-NP	O
of	of	IN	B-PP	O
ischemia	ischemia	NN	B-NP	O
but	but	CC	O	O
believed	believe	VBN	B-VP	O
to	to	TO	I-VP	O
be	be	VB	I-VP	O
2ndary	2ndary	JJ	B-ADJP	O
to	to	TO	B-PP	O
overBB	overBB	NN	B-NP	O
,	,	,	O	O
no	no	DT	B-NP	O
CP	CP	NN	I-NP	B-DNA
.	.	.	O	O

Known	Know	VBN	B-NP	O
Guaiac	Guaiac	NN	I-NP	O
+	+	SYM	B-NP	O
after	after	IN	B-PP	O
polypectomy	polypectomy	NN	B-NP	O
.	.	.	O	O

Denies	Deny	NNS	B-NP	O
N/V	N/V	NN	I-NP	O
,	,	,	O	O
abd	abd	NN	B-NP	O
pain	pain	NN	I-NP	O
,	,	,	O	O
F/C/NS	F/C/NS	NN	B-NP	B-protein
.	.	.	O	O

In	In	IN	B-PP	O
ED	ED	JJ	B-NP	O
pt	pt	NN	I-NP	O
.	.	.	O	O

given	give	VBN	B-NP	O
2L	2L	NN	I-NP	O
IVF	IVF	NN	I-NP	O
,	,	,	O	O
ASA	ASA	NN	B-NP	O
325	325	CD	I-NP	O
with	with	IN	B-PP	O
resolution	resolution	NN	B-NP	O
of	of	IN	B-PP	O
CP	CP	NN	B-NP	B-DNA
.	.	.	O	O

Initial	Initial	JJ	B-NP	O
TnI	TnI	NN	I-NP	O
<	<	SYM	B-NP	O
assay	assay	NN	I-NP	O
.	.	.	O	O

All	All	DT	B-NP	O
:	:	:	O	O
IV	IV	CD	B-NP	O
Nitroglyerin	Nitroglyerin	NN	I-NP	O
-	-	HYPH	O	O
>	>	SYM	B-NP	O
dizziness	dizziness	NN	I-NP	O
Soc	Soc	NN	I-NP	O
:	:	:	O	O
No	No	NNP	B-NP	O
Tob	Tob	NNP	I-NP	O
,	,	,	O	O
Rare	Rare	NNP	B-NP	O
EtOH	EtOH	NNP	I-NP	O
,	,	,	O	O
no	no	DT	B-NP	O
IVDU	IVDU	NN	I-NP	B-protein
.	.	.	O	O

Lives	Life	NNS	B-NP	O
with	with	IN	B-PP	O
wife	wife	NN	B-NP	O
in	in	IN	B-PP	O
Cosasbuff	Cosasbuff	NNP	B-NP	O
,	,	,	O	O
indep	indep	JJ	B-NP	O
ADLs	ADL	NNS	I-NP	O
.	.	.	O	O

FMH	FMH	NN	B-NP	O
:	:	:	O	O
Father	Fath	JJR	B-NP	O
MI	MI	NN	I-NP	O
at	at	IN	B-PP	O
age	age	NN	B-NP	O
65	65	CD	I-NP	O
PE	PE	NN	I-NP	O
:	:	:	O	O
97.0	97.0	CD	B-NP	O
55144/80	55144/80	CD	I-NP	O
16	16	CD	I-NP	O
98	98	CD	I-NP	O
%	%	NN	I-NP	O
RA	RA	NN	I-NP	O
NAD	NAD	NN	I-NP	O
.	.	.	O	O

no	no	DT	B-NP	O
JVD	JVD	NNP	I-NP	O
,	,	,	O	O
RRR	RRR	NNP	B-NP	O
II/VI	II/VI	NNP	I-NP	O
SEM	SEM	NNP	I-NP	O
RUSB	RUSB	NNP	I-NP	O
,	,	,	O	O
CTAB	CTAB	NN	B-NP	B-protein
,	,	,	O	O
abd	abd	NN	B-NP	O
benign	benign	JJ	B-ADJP	O
.	.	.	O	O

2	2	CD	B-NP	O
+	+	SYM	I-NP	O
femoral	femoral	JJ	I-NP	O
pulses	pulse	NNS	I-NP	O
,	,	,	O	O
no	no	DT	B-NP	O
bruits	bruit	NNS	I-NP	O
.	.	.	O	O

Data	Datum	NNS	B-NP	O
:	:	:	O	O
Hct	Hct	NN	B-NP	O
:	:	:	O	O
29.5	29.5	CD	B-NP	O
.	.	.	O	O

Cr	Cr	NN	B-NP	O
:	:	:	O	O
4.3	4.3	CD	B-NP	O
-LRB-	-LRB-	NN	I-NP	O
baseline	baseline	NN	I-NP	O
3.5	3.5	CD	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
Ca	Ca	NNP	I-NP	O
:	:	:	O	O
6.6	6.6	CD	B-NP	O
IoCa	IoCa	NNP	I-NP	O
:	:	:	O	O
0.87	0.87	CD	B-NP	O
.	.	.	O	O

CK	CK	NN	B-NP	B-protein
#	#	#	B-NP	I-protein
1	1	CD	I-NP	I-protein
:	:	:	O	O
127	127	CD	B-NP	O
,	,	,	O	O
MB	MB	NN	B-NP	B-protein
#	#	#	B-NP	I-protein
1	1	CD	I-NP	I-protein
:	:	:	O	O
1.5	1.5	CD	B-NP	O
,	,	,	O	O
TnI	TnI	NN	B-NP	B-protein
<	<	SYM	I-NP	O
assay	assay	NN	I-NP	O
.	.	.	O	O

EKG	EKG	NN	B-NP	O
:	:	:	O	O
Sinus	Sinus	NNP	B-NP	O
brady	brady	NN	I-NP	O
.	.	.	O	O

1st	1st	JJ	B-NP	O
degree	degree	NN	I-NP	O
AVB	AVB	NN	I-NP	O
.	.	.	O	O

Slightly	Slightly	RB	B-NP	O
prolonged	prolong	VBN	I-NP	O
QT	QT	NN	I-NP	O
.	.	.	O	O

+	+	SYM	B-NP	O
LVH	LVH	NN	I-NP	O
.	.	.	O	O

Hospital	Hospital	NN	B-NP	O
course	course	NN	I-NP	O
:	:	:	O	O
1	1	CD	B-NP	O
-RRB-	-RRB-	NN	I-NP	O
CV	CV	NN	I-NP	O
:	:	:	O	O
ROMI	ROMI	NN	B-NP	O
:	:	:	O	O
enzymes	enzyme	NNS	B-NP	O
x3	x3	NN	I-NP	O
neg	neg	NN	I-NP	O
.	.	.	O	O

No	No	DT	B-NP	O
further	further	JJ	I-NP	O
CP	CP	NN	I-NP	B-DNA
.	.	.	O	O

Cont	Cont	NNP	B-NP	O
.	.	.	O	O

ASA/lopressor/statin	ASA/lopressor/statin	NN	B-NP	O
-LRB-	-LRB-	NN	I-NP	O
inc	inc	NN	I-NP	O
to	to	TO	B-PP	O
80mg	80mg	CD	B-NP	O
given	give	VBN	I-NP	O
LDL	LDL	NN	I-NP	B-protein
=	=	SYM	B-VP	O
142	142	CD	B-NP	O
-RRB-	-RRB-	NN	I-NP	O
.	.	.	O	O

Cont	Cont	NNP	B-NP	O
.	.	.	O	O

Norvasc	Norvasc	UH	B-INTJ	B-cell_type
.	.	.	O	O

Held	Held	NNP	B-NP	O
Lasix	Lasix	NNP	I-NP	O
.	.	.	O	O

Repeat	Repeat	NNP	B-NP	O
ETT-MIBI	ETT-MIBI	NNP	I-NP	O
6/13/03	6/13/03	CD	I-NP	O
,	,	,	O	O
Bruce	Bruce	NNP	B-NP	O
protocol	protocol	NN	I-NP	O
showed	show	VBD	B-VP	O
interval	interval	JJ	B-NP	O
improvement	improvement	NN	I-NP	O
since	since	IN	B-PP	O
4/12	4/12	CD	B-NP	O
,	,	,	O	O
exercised	exercise	VBN	B-VP	O
5	5	CD	B-NP	O
:	:	:	O	O
15	15	CD	B-NP	O
stopped	stop	VBD	B-VP	O
due	due	IN	B-PP	O
to	to	TO	B-PP	O
fatigue	fatigue	NN	B-NP	O
,	,	,	I-NP	O
max	max	NN	I-NP	O
HR	HR	NN	I-NP	O
:	:	:	O	O
112	112	CD	B-NP	O
-LRB-	-LRB-	HYPH	I-NP	O
77	77	CD	I-NP	O
%	%	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
,	,	,	O	O
max	max	NN	B-NP	O
BP	BP	NN	I-NP	O
:	:	:	O	O
148	148	CD	B-NP	O
/	/	SYM	I-NP	O
75	75	CD	I-NP	O
,	,	,	O	O
terminated	terminate	VBN	B-VP	O
due	due	JJ	B-ADJP	O
to	to	TO	B-VP	O
fatigue	fatigue	VB	I-VP	O
,	,	,	O	O
no	no	DT	B-NP	O
ischemia	ischemia	NN	I-NP	O
noted	note	VBD	B-VP	O
,	,	,	O	O
no	no	DT	B-NP	O
arrythmias	arrythmia	NNS	I-NP	O
,	,	,	O	O
no	no	DT	B-NP	O
perfusion	perfusion	NN	I-NP	O
defects	defect	NNS	I-NP	O
noted	note	VBD	B-VP	O
,	,	,	O	O
peak	peak	JJ	B-NP	O
stress	stress	NN	I-NP	O
LVEF	LVEF	NN	I-NP	O
=	=	SYM	B-VP	O
61	61	CD	B-NP	O
%	%	NN	I-NP	O
.	.	.	O	O

On	On	IN	B-PP	O
tele	tele	NN	B-NP	O
without	without	IN	B-PP	O
events	event	NNS	B-NP	O
.	.	.	O	O

Prior	Prior	RB	B-ADVP	O
to	to	TO	B-PP	O
d/c	d/c	NN	B-NP	O
restarted	restart	VBD	B-VP	O
Lasix	Lasix	NNP	B-NP	O
40mg	40mg	CD	I-NP	O
bid	bid	NN	I-NP	O
and	and	CC	I-NP	O
Potassium	Potassium	NN	I-NP	O
.	.	.	O	O

2	2	CD	B-NP	O
-RRB-	-RRB-	NNP	I-NP	O
Endo	Endo	NNP	I-NP	O
:	:	:	O	O
DM	DM	NNP	B-NP	O
,	,	,	O	O
Cont	Cont	NNP	B-NP	O
.	.	.	O	O

Glypizide	Glypizide	NN	B-NP	O
.	.	.	O	O

RISS	RISS	NNP	B-NP	O
,	,	,	O	O
FSBS	FSBS	NNP	B-NP	O
wnl	wnl	NN	I-NP	O
.	.	.	O	O

3	3	CD	B-NP	O
-RRB-	-RRB-	NNP	I-NP	O
Renal	Renal	NNP	I-NP	O
:	:	:	O	O
Cr	Cr	NNP	B-NP	O
:	:	:	O	O
4.3	4.3	CD	B-NP	O
,	,	,	O	O
likely	likely	RB	B-ADJP	O
pre-renal	pre-renal	JJ	I-ADJP	O
.	.	.	O	O

Cr	Cr	NN	B-NP	O
improved	improve	VBN	B-VP	O
to	to	TO	B-PP	O
baseline	baseline	NN	B-NP	O
3.4	3.4	CD	I-NP	O
o	o	NN	I-NP	O
n	n	NN	I-NP	O
date	date	NN	I-NP	O
of	of	IN	B-PP	O
d/c	d/c	NN	B-NP	O
after	after	IN	B-PP	O
IVF	IVF	NN	B-NP	B-protein
.	.	.	O	O

Nephrocaps	Nephrocap	NNS	B-NP	O
started	start	VBD	B-VP	O
.	.	.	O	O

PTH	PTH	NN	B-NP	O
elevated	elevate	VBD	B-VP	O
at	at	IN	B-PP	O
242	242	CD	B-NP	O
.	.	.	O	O

Ca	Ca	NN	B-NP	O
:	:	:	O	O
6.6	6.6	CD	B-NP	O
/	/	SYM	I-NP	O
IoCa	IoCa	NN	I-NP	O
:	:	:	O	O
0.8	0.8	CD	B-NP	O
7	7	CD	I-NP	O
on	on	IN	B-PP	O
admission	admission	NN	B-NP	O
,	,	,	O	O
repleted	replete	VBN	B-VP	O
.	.	.	O	O

Start	Start	NNP	B-NP	O
PhosLo	PhosLo	NNP	I-NP	O
for	for	IN	B-PP	O
low	low	JJ	B-NP	O
Ca	Ca	NN	I-NP	O
,	,	,	O	O
high	high	JJ	B-NP	O
PO4	PO4	NN	I-NP	B-protein
.	.	.	O	O

Epo	Epo	NN	B-NP	B-protein
started	start	VBD	B-VP	O
11/19	11/19	CD	B-NP	O
as	as	IN	B-PP	O
outpt	outpt	NN	B-NP	O
,	,	,	O	O
did	do	VBD	B-VP	O
not	not	RB	I-VP	O
do	do	VB	I-VP	O
in-house	in-house	JJ	B-ADVP	O
.	.	.	O	O

Pt	Pt	NN	B-NP	O
.	.	.	O	O

will	will	MD	B-VP	O
require	require	VB	I-VP	O
close	close	RB	B-ADVP	O
out	out	RP	B-PRT	O
pt	pt	JJ	B-NP	O
monitoring	monitoring	NN	I-NP	O
of	of	IN	B-PP	O
CRI	CRI	NN	B-NP	B-protein
,	,	,	O	O
consider	consider	VBP	B-VP	O
dialysis	dialysis	NN	B-NP	O
as	as	IN	B-PP	O
outpt.Also	outpt.Also	NN	B-NP	O
consider	consider	NN	I-NP	O
checking	check	VBG	B-VP	O
Vit	Vit	NNP	B-NP	O
D	D	NNP	I-NP	O
level	level	NN	I-NP	O
and	and	CC	O	O
adding	add	VBG	B-VP	O
calcitriol	calcitriol	NN	B-NP	O
.	.	.	O	O

4	4	CD	B-NP	O
-RRB-	-RRB-	NNP	I-NP	O
FEN	FEN	NNP	I-NP	O
:	:	:	O	O
IVF	IVF	NN	B-NP	O
hydration	hydration	NN	I-NP	O
.	.	.	O	O

K	K	NN	B-NP	O
:	:	:	O	O
2.9	2.9	CD	B-NP	O
on	on	IN	B-PP	O
admission	admission	NN	B-NP	O
,	,	,	O	O
repleted	replete	VBN	B-VP	O
.	.	.	O	O

ADA	ADA	NN	B-NP	O
2100kcal/low	2100kcal/low	CD	I-NP	O
fat/salt	fat/salt	NN	I-NP	O
.	.	.	O	O

5	5	CD	B-NP	O
-RRB-	-RRB-	NN	I-NP	O
Prophyl	Prophyl	NN	I-NP	O
:	:	:	O	O
Ted	Ted	JJ	B-NP	O
stockings	stocking	NNS	I-NP	O
.	.	.	O	O

Nexium	Nexium	NN	B-NP	O
for	for	IN	B-PP	O
GI	GI	NN	B-NP	O
.	.	.	O	O

6	6	CD	B-NP	O
-RRB-	-RRB-	NNP	I-NP	O
Heme	Heme	NNP	I-NP	O
:	:	:	O	O
Hct	Hct	NN	B-NP	O
26.6	26.6	CD	I-NP	O
repleted	replete	VBN	B-VP	O
with	with	IN	B-PP	O
2U	2U	NN	B-NP	B-cell_type
pRBCs	pRBC	NNS	I-NP	I-cell_type
,	,	,	O	O
with	with	IN	B-PP	O
post-transfusion	post-transfusion	JJ	B-NP	O
Hct	Hct	NN	I-NP	O
:	:	:	O	O
32.8	32.8	CD	B-NP	O
.	.	.	O	O

Guaiac	Guaiac	NN	B-NP	O
negative	negative	JJ	B-ADJP	O
.	.	.	O	O

7	7	CD	B-NP	O
-RRB-	-RRB-	NNP	I-NP	O
Code	Code	NNP	I-NP	O
:	:	:	O	O
Full	Full	NNP	B-NP	O
ADDITIONAL	ADDITIONAL	NNP	I-NP	O
COMMENTS	COMMENTS	NNS	I-NP	O
:	:	:	O	O
You	You	PRP	B-NP	O
were	be	VBD	B-VP	O
admitted	admit	VBN	I-VP	O
for	for	IN	B-PP	O
chest	chest	NN	B-NP	O
pain	pain	NN	I-NP	O
that	that	WDT	B-NP	O
was	be	VBD	B-VP	O
subsequently	subsequently	RB	I-VP	O
found	find	VBN	I-VP	O
to	to	TO	I-VP	O
not	not	RB	I-VP	O
be	be	VB	I-VP	O
a	a	DT	B-NP	O
heart	heart	NN	I-NP	O
attack	attack	NN	I-NP	O
.	.	.	O	O

A	A	DT	B-NP	O
repeat	repeat	NN	I-NP	O
excercise	excercise	NN	I-NP	O
stress	stress	NN	I-NP	O
test	test	NN	I-NP	O
was	be	VBD	B-VP	O
repeated	repeat	VBN	I-VP	O
since	since	IN	B-PP	O
4/12	4/12	CD	B-NP	O
to	to	TO	B-VP	O
evaluate	evaluate	VB	I-VP	O
your	your	PRP$	B-NP	O
heart	heart	NN	I-NP	O
and	and	CC	O	O
it	it	PRP	B-NP	O
showed	show	VBD	B-VP	O
that	that	IN	B-SBAR	O
your	your	PRP$	B-NP	O
heart	heart	NN	I-NP	O
is	be	VBZ	B-VP	O
in	in	IN	B-PP	O
better	good	JJR	B-NP	O
health	health	NN	I-NP	O
.	.	.	O	O

You	You	PRP	B-NP	O
were	be	VBD	B-VP	O
started	start	VBN	I-VP	O
on	on	IN	B-PP	O
Nephrocaps	Nephrocaps	NNP	B-NP	O
and	and	CC	I-NP	O
PhosLo	PhosLo	NNP	I-NP	O
for	for	IN	B-PP	O
your	your	PRP$	B-NP	O
kidne	kidne	NN	I-NP	O
y	y	NN	I-NP	O
condition	condition	NN	I-NP	O
.	.	.	O	O

Please	Please	NN	B-NP	O
follow-up	follow-up	NN	I-NP	O
with	with	IN	B-PP	O
Dr.	Dr.	NNP	B-NP	O
Lett	Lett	NNP	I-NP	O
as	as	IN	B-PP	O
schedule	schedule	NN	B-NP	O
for	for	IN	B-PP	O
10/20	10/20	CD	B-NP	O
.	.	.	O	O

If	If	IN	B-SBAR	O
you	you	PRP	B-NP	O
feel	feel	VBP	B-VP	O
chest	chest	NN	B-NP	O
pain	pain	NN	I-NP	O
,	,	,	O	O
dizziness	dizziness	NN	B-NP	O
or	or	CC	O	O
shortness	shortness	NN	B-NP	O
of	of	IN	B-PP	O
breath	breath	NN	B-NP	O
,	,	,	O	O
please	please	VB	B-INTJ	O
call	call	VB	B-VP	O
your	your	PRP$	B-NP	O
doctor	doctor	NN	I-NP	O
or	or	CC	O	O
come	come	VBN	B-VP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
ER	ER	NN	I-NP	B-protein
.	.	.	O	O

DISCHARGE	DISCHARGE	NN	B-NP	O
CONDITION	CONDITION	NN	I-NP	O
:	:	:	O	O
Stable	Stable	JJ	B-NP	O
TO	TO	NN	I-NP	O
DO/PLAN	DO/PLAN	NN	I-NP	O
:	:	:	O	O
Please	Please	NN	B-NP	O
follow-up	follow-up	NN	I-NP	O
with	with	IN	B-PP	O
your	your	PRP$	B-NP	O
primary	primary	JJ	I-NP	O
care	care	NN	I-NP	O
provider	provider	NN	I-NP	O
,	,	,	O	O
Dr.	Dr.	NNP	B-NP	O
Nacion	Nacion	NNP	I-NP	O
at	at	IN	B-PP	O
IMC	IMC	NNP	B-NP	O
Tulifro	Tulifro	NNP	I-NP	O
Dr.	Dr.	NNP	I-NP	O
You	You	PRP	B-NP	O
have	have	VBP	B-VP	O
an	an	DT	B-NP	O
appointment	appointment	NN	I-NP	O
scheduled	schedule	VBN	B-VP	O
for	for	IN	B-PP	O
Friday	Friday	NNP	B-NP	O
10/20	10/20	CD	I-NP	O
at	at	IN	B-PP	O
9	9	CD	B-NP	O
:	:	SYM	I-NP	O
20	20	CD	I-NP	O
am	am	NN	I-NP	O
.	.	.	O	O

You	You	PRP	B-NP	B-protein
will	will	MD	B-VP	O
need	need	VB	I-VP	O
outpatient	outpatient	NN	B-NP	O
follow-up	follow-up	NN	I-NP	O
for	for	IN	B-PP	O
your	your	PRP$	B-NP	O
chronic	chronic	JJ	I-NP	O
renal	renal	JJ	I-NP	O
insufficiency	insufficiency	NN	I-NP	O
.	.	.	O	O

No	No	DT	B-NP	O
dictated	dictated	JJ	I-NP	O
summary	summary	NN	I-NP	O
ENTERED	ENTERED	NNP	I-NP	O
BY	BY	NNP	I-NP	O
:	:	:	O	O
SVANCARA	SVANCARA	NNP	B-NP	O
,	,	,	O	O
BRADLEY	BRADLEY	NNP	B-NP	O
A.	A.	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
-LRB-	-LRB-	NNP	I-NP	O
LE75	LE75	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
7/1/03	7/1/03	CD	I-NP	O
@	@	NN	I-NP	O
03	03	CD	I-NP	O
:	:	:	O	O
42	42	CD	B-NP	O
PM	PM	NN	I-NP	O
******	******	SYM	B-NP	O
END	END	NN	I-NP	O
OF	OF	IN	B-PP	O
DISCHARGE	DISCHARGE	NN	B-NP	O
ORDERS	ORDERS	NNS	I-NP	O
******	******	SYM	B-NP	O

